Citations for: Sitruk-Ware, R.; El-Etr, M., Progesterone and related progestins: potential new health benefits. Climacteric 2013, 16, 69-78.

Entry Type
Name
Value
Parent Entry
Pharmacology Data Field
Androgen Receptor Activity
Antagonist (40% of CPA, the most potent anti-androgenic progestin)
Dienogest (API)
Pharmacology Data Field
Mineralocorticoid Receptor Activity
Antagonist (antimineralocorticoid or aldosterone antagonist). Agonist reports vary: "weak" (Africander) to "strong" (Bartsch).
Drospirenone (API)